Funds · compare two funds
Are these two funds really different?
Pick two funds to see how much of their Indian equity is the same: the companies both hold, and what each holds that the other does not.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
Baroda BNP Paribas Health and Wellness Fund vs Mirae Asset Nifty 500 Healthcare ETF
Overlap adds up, for every company both funds hold, the smaller of its two shares of each fund’s disclosed Indian equity: identical portfolios overlap 100%, funds with nothing in common 0%. A figure describes how alike the portfolios are; it is not a judgement of either fund. Method →
See both funds combined in the Portfolio X-ray →
Top shared holdings
24 companies both funds hold · largest common part first
Only in A
9 companies · largest first
- AstraZeneca Pharma India Limited2.88%
- Max Financial Services Limited2.28%
- Symbiotec Pharmalab Limited1.51%
- Nephrocare Health Services Limited1.46%
- Metropolis Healthcare Limited1.37%
- Manipal Health Enterprises Limited1.27%
- Inventurus Knowledge Solutions Limited0.92%
- Life Insurance Corporation Of India0.48%
- Procter & Gamble Health Limited0.18%
Only in B
20 companies · largest first
- Max Healthcare Institute Limited5.13%
- Alkem Laboratories Limited2.31%
- Biocon Limited1.91%
- Sai Life Sciences Limited1.56%
- Krishna Institute of Medical Sciences Limited1.48%
- Neuland Laboratories Limited1.36%
- Wockhardt Limited1.30%
- Piramal Pharma Limited0.95%
- Granules India Limited0.93%
- Global Health Limited0.90%
- Onesource Specialty Pharma Limited0.89%
- Anthem Biosciences Limited0.69%
- Natco Pharma Limited0.55%
- Cohance Lifesciences Limited0.54%
- Vijaya Diagnostic Centre Limited0.52%
And 5 more.
Sector mix side by side
Share of each fund’s disclosed equity
| Sector | A | B | Difference |
|---|---|---|---|
| Healthcare | 90.7% | 100.0% | -9.34 pp |
| Financial Services | 2.8% | 0.0% | +2.76 pp |
| Information Technology | 0.9% | 0.0% | +0.92 pp |
| Not classified | 5.7% | 0.0% | +5.66 pp |
Built from each fund’s latest monthly disclosure of Indian listed shares, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not part of the comparison. Not a recommendation. Method →